| | | | | Oil prices dropped more than 1 percent on Tuesday on signs of rising supply and concern that global economic growth and demand for fuel will fall victim to the U.S.-China trade war. | | |
| | | Apple Inc refreshed some of its lesser-known products at a New York event on Tuesday, adding iPhone features like facial recognition to the iPad Pro and faster processors and better displays to some Mac computers that had gone years without a major update. | | |
| | | Chinese electric vehicle developer Faraday Future's co-founder Nick Sampson has resigned, tech news website Verge reported on Tuesday, a week after the cash-starved company planned pay cuts and layoffs to reduce operational costs. | | |
| | | Major U.S. stock indexes posted modest gains on Tuesday, helped by gains for chip stocks as investors took advantage of cheaper prices following a steep recent pullback for equities. | | |
| | | Bain Capital and CVC Capital Partners are among the private equity firms competing to acquire Papa John's International Inc , the world's third-largest pizza delivery company, people familiar with the matter said on Tuesday. | | |
| | | Investment firm Third Point LLC and Campbell Soup Co squared off over plans for the company's future on Tuesday, with the hedge fund pushing for hiring a "highly qualified" chief executive officer and the company saying it was already searching for a permanent chief. | | |
| | | Broad gains in the U.S. equity market turned global stocks higher on Tuesday after President Donald Trump said a "great deal" could be struck with China that would relieve fears of a growing trade war between the world's two largest economies. | | |
| | | Fiat Chrysler (FCA) reported better-than-expected third-quarter earnings and promised to pay 2 billion euros ($2.3 billion) in special dividends, but a lower net cash forecast and its over-reliance on the North American market weighed on its shares. | | |
| | | Pfizer Inc on Tuesday reported worse-than-expected third quarter revenue and lowered the top end of its full-year sales forecast as generic competition and drug pricing pressure in the United States hurt its older drugs business. | | |
| | | Mastercard's shares reversed course to fall sharply in afternoon trading on Tuesday as investors worried the company's third-quarter revenue growth was largely being driven by rebates and incentives and not by transaction volumes. | | |
|
| |
